医学
乳腺癌
临床实习
全身疗法
转移性乳腺癌
重症监护医学
肿瘤科
疾病
癌症
阶段(地层学)
临床肿瘤学
内科学
医学物理学
家庭医学
生物
古生物学
作者
William J. Gradishar,Meena S. Moran,Jame Abraham,Vandana G. Abramson,Rebecca Aft,Doreen M. Agnese,Kimberly H. Allison,Bethany Anderson,Harold J. Burstein,Helen K. Chew,Chau T. Dang,Anthony Elias,Sharon H. Giordano,Matthew P. Goetz,Lori J. Goldstein,Sara A. Hurvitz,Rachel C. Jankowitz,Sara H. Javid,Jairam Krishnamurthy,A. Marilyn Leitch
出处
期刊:Journal of The National Comprehensive Cancer Network
日期:2023-06-01
卷期号:21 (6): 594-608
被引量:346
标识
DOI:10.6004/jnccn.2023.0031
摘要
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Breast Cancer address all aspects of management for breast cancer. The treatment landscape of metastatic breast cancer is evolving constantly. The therapeutic strategy takes into consideration tumor biology, biomarkers, and other clinical factors. Due to the growing number of treatment options, if one option fails, there is usually another line of therapy available, providing meaningful improvements in survival. This NCCN Guidelines Insights report focuses on recent updates specific to systemic therapy recommendations for patients with stage IV (M1) disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI